A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Lupus Erythematosus, Systemic

In brief

The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immune system mistakenly attacks its own healthy tissues, causing swelling and redness in various organs).

Key facts

Study ID
NCT07438496
Run by
Janssen Research & Development, LLC
People needed
600
Starts
2026-03-05
Expected to finish
2031-11-07
Last updated by the study team
2026-07-31

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.